Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries

Life Sciences

Volumn 193, Issue , 2018, Pages 64-76

  Hassanzadeh, Parichehr ^a   Arbabi, Elham ^b   Atyabi, Fatemeh ^a   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ferulic acid; Ischemic stroke; Nanostructured lipid carriers; Phosphoinositide 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CATALASE; DRUG CARRIER; FERULIC ACID; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; PHOSPHATIDYLINOSITOL 3 KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; WATER; COUMARIC ACID; GLUCOSE; LIPID; NEUROPROTECTIVE AGENT; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL LOSS; CELL NUCLEUS; CELL PROTECTION; CELL VIABILITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSITY; DRUG EFFECT; DRUG SCREENING; DRUG SOLUBILITY; ENZYME ACTIVITY; EXPERIMENTAL CEREBRAL ISCHEMIA; HIPPOCAMPAL CA1 REGION; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MALE; MEMORY; NANOPHARMACEUTICS; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PC12 CELL LINE; PHYSICAL CHEMISTRY; RAT; REPERFUSION INJURY; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; BRAIN ISCHEMIA; CELL SURVIVAL; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; GLUCOSE; LIPIDS; MALE; NANOSTRUCTURES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXYGEN; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; RATS; RATS, WISTAR; REPERFUSION INJURY; STROKE; SUPEROXIDE DISMUTASE;

EID: 85037712518     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2017.11.046     Document Type: Article

References (69)

1. Klijn, C.J., Hankey, G.J., Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol. 2 (2003), 698–701.
2. Moskowitz, M.A., Lo, E.H., Iadecola, C., The science of stroke: mechanisms in search of treatments. Neuron 67 (2010), 181–198.
3. Serteser, M., Ozben, T., Gumuslu, S., Balkan, S., Balkan, E., The effects of NMDA receptor antagonist MK-801 on lipid peroxidation during focal cerebral ischemia in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002), 871–877.
4. Xu, L., Sun, J., Lu, R., Ji, Q., Xu, J.G., Effect of glutamate on inflammatory responses of intestine and brain after focal cerebral ischemia. World J. Gastroenterol. 11 (2005), 733–736.
5. Chen, H., Yoshioka, H., Kim, G.S., Jung, J.E., Okami, N., Sakata, H. et al., Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox Signal. 14 (2011), 1505–1517.
6. Gohil, K.J., Kshirsagar, S.B., Sahane, R.S., Ferulic acid-a comprehensive pharmacology of an important bioflavonoid. Int. J. Pharm. Sci. Res. 3 (2012), 700–710.
7. Srinivasan, M., Sudheer, A.R., Menon, V.P., Ferulic acid: therapeutic potential through its antioxidant property. J. Clin. Biochem. Nutr. 40 (2007), 92–100.
8. Wu, W., Lee, S.Y., Wu, X., Tyler, J.Y., Wang, H., Ouyang, Z. et al., Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord. Biomaterials 35 (2014), 2355–2364.
9. Cheng, C.Y., Ho, T.Y., Lee, E.J., Su, S.Y., Tang, N.Y., Hsieh, C.L., Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am. J. Chin. Med. 36 (2008), 1105–1119.
10. Yan, J.J., Cho, J.Y., Kim, H.S., Kim, K.L., Jung, J.S., Huh, S.O. et al., Protection against b-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133 (2001), 89–96.
11. Hassanzadeh, P., Arbabi, E., Atyabi, F., Dinarvand, R., Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy. Life Sci. 179 (2017), 9–14.
12. Hong, Q., Ma, Z.C., Huang, H., Wang, Y.G., Tan, H.L., Xiao, C.R. et al., Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling. Eur. J. Pharmacol. 777 (2016), 1–8.
13. Ou, S., Kwok, K.C., Ferulic acid: pharmaceutical functions, preparation and applications in foods. J. Sci. Food Agric. 84 (2004), 1261–1269.
14. Sohn, Y.T., Oh, J.H., Characterization of physicochemical properties of ferulic acid. Arch. Pharm. Res. 26 (2003), 1002–1008.
15. Bharali, D.J., Siddiqui, I.A., Adhami, V.M., Chamcheu, J.C., Aldahmash, A.M., Mukhtar, Hasan et al., Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects. Cancers (Basel) 3 (2011), 4024–4045.
16. Sharma, M., Sharma, R., Jain, D.K., Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Australas. Sci., 2016, 2016, 8525679.
17. Hassanzadeh, P., Arbabi, E., Rostami, F., Atyabi, F., Dinarvand, R., Carbon nanotubes prolong the regulatory action of nerve growth factor on the endocannabinoid signaling. Physiol. Pharmacol. 19 (2015), 167–176.
18. Hassanzadeh, P., Arbabi, E., Atyabi, F., Dinarvand, R., Carbon nanotube-anandamide complex exhibits sustained protective effects in an in vitro model of stroke. Physiol. Pharmacol. 20 (2016), 12–23.
19. Hassanzadeh, P., Arbabi, E., Atyabi, F., Dinarvand, R., Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: towards a novel treatment strategy in colitis. Life Sci. 179 (2017), 66–72.
20. Hassanzadeh, P., Arbabi, E., Atyabi, F., Dinarvand, R., Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke. Life Sci. 179 (2017), 15–22.
21. Anjana, M.N., Jipnomon, J., Sreeja, C.N., Solubility enhancement methods - a promising technology for poorly water soluble drugs. Int. J. Pharm. Sci. Rev. Res. 22 (2013), 127–134.
22. Ghosh, A., Sarkar, S., Mandal, A.K., Das, N., Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One, 8, 2013, e57735.
23. Kim, D., Chun, B.G., Kim, Y.K., Lee, Y.H., Park, C.S., Jeon, I. et al., In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant. 16 (2008), 1007–1012.
24. Marsh, J.N., Hu, G., Scott, M.J., Zhang, H., Goette, M.J., Gaffney, P.J. et al., A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Int. J. Nanomedicine 7 (2012), 5137–5149.
25. Müller, R.H., Lipid nanoparticles: recent advances. Adv. Drug Deliv. Rev. 59 (2007), 375–376.
26. Müller, R.H., Rühl, D., Runge, S., Schulze-Forster, K., Mehnert, W., Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 14 (1997), 458–462.
27. Freitas, C., Müller, R.H., Correlation between long-term stability of solid lipid nanoparticles (SLNs) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47 (1999), 125–132.
28. Kumbhar, D.D., Pokharkar, V.B., Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: physicochemical investigations. Colloids Surf. A Physicochem. Eng. Asp. 416 (2013), 32–42.
29. Li, F., Weng, Y., Wang, L., He, H., Yang, J., Tang, X., The efficacy and safety of bufadienolides loaded nanostructured lipid carriers. Int. J. Pharm. 393 (2010), 203–211.
30. Cantley, L.C., The phosphoinositide 3-kinase pathway. Science 296 (2002), 1655–1657.
31. Mullonkal, C.J., Toledo-Pereyra, L.H., Akt in ischemia and reperfusion. J. Investig. Surg. 20 (2007), 195–203.
32. Beloqui, A., Solinís, M.Á., Gascón, A.R., del Pozo-Rodríguez, A., des Rieux, A., Préat, V., Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J. Control. Release 166 (2013), 115–123.
33. Yang, R., Zhang, S., Kong, D., Gao, X., Zhao, Y., Wang, Z., Biodegradable polymercurcumin conjugate micelles enhance the loading and delivery of low potency curcumin. Pharm. Res., 29, 2012, 3512e25.
34. Mehta, S.L., Manhas, N., Raghubir, R., Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 54 (2007), 34–66.
35. Larsen, E.C., Hatcher, J.F., Adibhatla, R.M., Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen–glucose deprivation in PC12 cells. Neuroscience 146 (2007), 946–961.
36. Koha, S.H., Kwon, H., Parka, K.H., Ko, J.K., Kim, J.H. et al., Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells. Mol. Brain Res. 133 (2005), 176–186.
37. Zakharova, I.O., Sokolova, T.V., Bayunova, L.V., Vlasova, Y.A., α-tocopherol at nanomolar concentration protects PC12 cells from hydrogen peroxide-induced death and modulates protein kinase activities. Int. J. Mol. Sci. 13 (2012), 11543–11568.
38. Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., Mitchell, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47 (1987), 936–941.
39. Decker, T., Lohmann-Matthes, M.L., A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115 (1988), 61–69.
40. Zhao, J., Bai, Y., Zhang, C., Zhang, X., Zhang, Y.X., Chen, J., L. et al., Cinepazide maleate protects PC12 cells against oxygen–glucose deprivation-induced injury. Neurol. Sci. 35 (2014), 875–881.
41. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
42. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
43. Jollow, D.J., Mitchell, J.R., Zampaglione, N., Gillette, J.R., Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 11 (1974), 151–169.
44. Kakkar, P., Das, B., Viswanathan, P.N., A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21 (1984), 130–132.
45. Aebi, H., Catalase in vitro. Methods Enzymol. 105 (1984), 121–126.
46. Zhaoa, C., Fana, T., Yanga, Y., Wua, M., Li, L., Zhoua, Z. et al., Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers. Int. J. Pharm. 450 (2013), 11–20.
47. Wang, M.T., Jin, Y., Yang, Y.X., Zhao, C.Y., Yang, H.Y., Xu, X.F. et al., In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system. Int. J. Nanomedicine 5 (2010), 487–497.
48. Pulsinelli, W.A., Brierley, J.B., A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10 (1979), 267–272.
49. Hu, X., Xie, C., He, S., Zhang, Y., Li, Y., Jiang, L., Remifentanil postconditioning improves global cerebral ischemia induced spatial learning and memory deficit in rats via inhibition of neuronal apoptosis through the PI3K signaling pathway. Neurol. Sci. 34 (2013), 1955–1962.
50. Zhang, R., Yang, G., Wang, Q., Guo, F., Wang, H., Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis. Mol. Biol. Rep. 40 (2013), 51–58.
51. Longa, E.Z., Weinstein, P.R., Carlson, S., Cummins, R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989), 84–91.
52. Morris, R., Developments of a water-maze procedure form studying spatial learning in the rat. J. Neurosci. Methods 11 (1984), 47–60.
53. Hassanzadeh, P., Arbabi, E., Rostami, F., The ameliorative effects of sesamol against seizures, cognitive impairment and oxidative stress in the experimental model of epilepsy. Iran J. Basic Med. Sci. 17 (2014), 100–107.
54. Goldlust, E.J., Paczynski, R.P., He, Y.Y., Hsu, C.Y., Goldberg, M.P., Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. Stroke 27 (1996), 1657–1662.
55. Zhang, W., Miao, Y., Zhou, S., Jiang, J., Luo, Q., Qiu, Y., Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase. J. Clin. Neurosci. 18 (2011), 685–689.
56. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. 2007, Academic, San Diego.
57. Habauzit, V., Morand, C., Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther. Adv. Chronic Dis 3 (2011), 87–106.
58. Hassanzadeh, P., Atyabi, F., Dinarvand, R., Resvertrol: more than a phytochemical. Biomed. Rev. 26 (2015), 13–21.
59. Hassanzadeh, P., Arbabi, E., Atyabi, F., Dinarvand, R., The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. Psychopharmacology 233 (2016), 1087–1096.
60. Manach, C., Williamson, G., Morand, C., Scalbert, A., Rémésy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 (2005), 230S–242S.
61. Siekmann, B., Westesen, K., Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf. B: Biointerfaces 3 (1994), 159–175.
62. Draper, H.H., Hadley, M., Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 186 (1990), 421–431.
63. Spitz, D.R., Sullivan, S.J., Malcolm, R.R., Roberts, R.J., Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 11 (1991), 415–423.
64. Warner, D.S., Sheng, H., Batinic-Haberle, I., Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207 (2004), 3221–3231.
65. Michiels, C., Raes, M., Toussaint, O., Remacle, J., Importance of glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17 (1994), 235–248.
66. Schmidt-Kastner, R., Freund, T.F., Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 4 (1991), 599–636.
67. White, B.C., Sullivan, J.M., DeGracia, D.J., O'Neil, B.J., Neumar, R.W., Grossman, L.I. et al., Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179 (2000), 1–33.
68. Cui, K., Luo, X., Xu, K., Murthy, M.R.V., Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004), 771–799.
69. Ojha, S., Javed, H., Abul Khair, S.A.S., Haque, E., Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease. Drug Des. Devel. Ther. 9 (2015), 5499–5510.